NCT05974280View on ClinicalTrials.gov

Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

January 2, 2025

Study Completion Date

June 30, 2025

Conditions
Crohn DiseaseAnal Fistula
Interventions
DRUG

Alofisel

Alofisel is made up of 'mesenchymal stem cells' from the fat tissue of a donor. Alofisel is a medicine that is used to treat complex anal fistulas in adults with Crohn's disease

DRUG

Fat stem cell

mesenchymal stem cells from adipose (fat) tissue injection

Trial Locations (1)

44000

RECRUITING

CHU Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER